Um caso de segurança de implantação para diagnóstico de câncer de próstata assistido por IA.
PMID: 40345136 ·
Y, a, n, , J, i, a, ;, , C, l, a, r, e, , V, e, r, r, i, l, l, ;, , K, i, e, r, o, n, , W, h, i, t, e, ;, , M, o, n, i, c, a, , D, o, l, t, o, n, ;, , M, a, r, g, a, r, e, t, , H, o, r, t, o, n, ;, , M, u, f, a, d, d, a, l, , J, a, f, f, e, r, j, i, ;, , I, b, r, a, h, i, m, , H, a, b, l, i
Publicidade
Resumo
Deep learning (DL) has the potential to deliver significant clinical benefits. In recent years, an increasing number of DL-based systems have been approved by the relevant regulators, e.g. FDA. Although obtaining regulatory approvals is a prerequisite to deploy such systems for real world use, it may not be sufficient. Regulatory approvals give confidence in the development process for such systems, but new hazardous events can arise depending on how the systems have been deployed in the intende
Publicidade
Fonte oficial
Ver no PubMed →Dados provenientes do PubMed / NCBI. Para consultar o texto integral e as informações mais recentes, recorra sempre ao registo oficial.